3D-MoRSE descriptors explained

被引:126
作者
Devinyak, Oleg [1 ]
Havrylyuk, Dmytro [2 ]
Lesyk, Roman [2 ]
机构
[1] Uzhgorod Natl Univ, Dept Pharmaceut Disciplines, UA-88000 Uzhgorod, Ukraine
[2] Danylo Halytsky Lviv Natl Med Univ, Dept Pharmaceut Organ & Bioorgan Chem, UA-79010 Lvov, Ukraine
关键词
3D-MoRSE descriptors; QSAR; Radial basis function; Descriptor interpretation; Structure encoding; QUANTITATIVE STRUCTURE-ACTIVITY; QSAR ANALYSIS; DERIVATIVES; PREDICTION; CYTOTOXICITY; REGRESSION;
D O I
10.1016/j.jmgm.2014.10.006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
3D-MoRSE is a very flexible 3D structure encoding framework for chemoinformatics and QSAR purposes due to the range of scattering parameter values and variety of weighting schemes used. While arising in many QSAR studies, up to this time they were considered as hardly interpreted and were treated like a "black box". This study is intended to lift the veil of mystery, providing a comprehensible way to the interpretation of 3D-MoRSE descriptors in QSAR/QSPR studies. The values of these descriptors are calculated with rather simple equation, but may vary when using differing starting geometries as optimization input. This variation increases with scattering parameter and also is higher for electronegativity weighted and unweighted descriptors. Though each 3D-MoRSE descriptor incorporates the information about the whole molecule structure, its final value is derived mostly from short-distance (up to 3 angstrom) atomic pairs. And, if a QSAR study covers structurally similar set of compounds, then the role of 3D-MoRSE descriptor in a model can be interpreted using just several pairs of neighbor atoms. The guide to interpretation process is discussed and illustrated with a case study. Realizing the mathematical concept behind 3D-descriptors and knowing their properties it is easy not only to interpret, but also to predict the importance of 3D-MoRSE descriptors in a QSAR study. The process of prediction is described on the practical example and its accuracy is confirmed with further QSAR modeling. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:194 / 203
页数:10
相关论文
共 28 条
  • [1] [Anonymous], 2012, R LANG ENV STAT COMP
  • [2] Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks
    Caballero, J
    Fernández, M
    [J]. JOURNAL OF MOLECULAR MODELING, 2006, 12 (02) : 168 - 181
  • [3] Docking and quantitative structure-activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase
    Caballero, Julio
    Vergara-Jaque, Ariela
    Fernandez, Michael
    Coll, Deysma
    [J]. MOLECULAR DIVERSITY, 2009, 13 (04) : 493 - 500
  • [4] ChemoPy: freely available python']python package for computational biology and chemoinformatics
    Cao, Dong-Sheng
    Xu, Qing-Song
    Hu, Qian-Nan
    Liang, Yi-Zeng
    [J]. BIOINFORMATICS, 2013, 29 (08) : 1092 - 1094
  • [5] Prediction of cytotoxicity data (CC50) of anti-HIV 5-pheny-1-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg-Marquardt algorithm
    Chamjangali, M. Arab
    Beglari, M.
    Bagherian, G.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2007, 26 (01) : 360 - 367
  • [6] QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors
    Cheng, Zhengjun
    Zhang, Yuntao
    Fu, Weizhong
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3970 - 3980
  • [7] The CoMFA steroids as a benchmark dataset for development of 3D QSAR methods
    Coats, EA
    [J]. PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1998, 12 : 199 - 213
  • [8] How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR)
    Dearden, J. C.
    Cronin, M. T. D.
    Kaiser, K. L. E.
    [J]. SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2009, 20 (3-4) : 241 - 266
  • [9] Quantitative structure-activity relationship study and directed synthesis of Thieno[2,3-d]pyrimidine-2,4-diones as monocarboxylate transporter 1 inhibitors
    Devinyak, O. T.
    Slivka, Mikh. V.
    Slivka, Mar. V.
    Vais, V. M.
    Lendel, V. G.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) : 2263 - 2272
  • [10] Devinyak O, 2012, CURR TOP MED CHEM, V12, P2763